Concentrix ($CNXC) Sees Q1 Revenue Growth, EPS Decline Year-Over-Year

Concentrix (NASDAQ: CNXC) announced its financial results for the first quarter of 2026, with revenue surpassing expectations and earnings per share falling below forecasts. The company experienced an increase in revenue compared to a year earlier, while earnings per share declined.

The company reported adjusted earnings per share of $2.61 for the first quarter of 2026, which was below the analyst estimate of $2.65. This reflects a decrease from the $2.79 per share recorded in the same period last year.

Concentrix achieved revenue of $2.5 billion for the first quarter of 2026, slightly exceeding the analyst estimate of $2.49 billion. This marks an increase from the $2.37 billion reported in the same quarter a year earlier.

Operating income for the first quarter of 2026 was $118.6 million, representing 4.7 percent of revenue, compared to $168.9 million, or 7.1 percent of revenue, in the prior year.

Non-GAAP operating income for the quarter was $295.0 million, or 11.8 percent of revenue, compared to $321.5 million, or 13.6 percent of revenue, a year earlier. Adjusted EBITDA was $348.2 million, or 13.9 percent of revenue, compared to $374.2 million, or 15.8 percent of revenue, in the prior year.

Looking ahead, Concentrix forecasts full-year earnings per share to range between $11.48 and $12.07, aligning with analyst expectations of $11.87. For the second quarter, earnings per share are expected to be between $2.57 and $2.69, which is below the projected $2.76.

The company anticipates full-year revenue to be between $10.04 billion and $10.18 billion, closely matching the forecasted $10.13 billion. For the second quarter, revenue is projected to range from $2.46 billion to $2.49 billion, aligning with the estimated $2.49 billion.

Concentrix paid a quarterly dividend of $0.36 per share on February 10, 2026, and has declared a similar dividend payable on May 5, 2026.

The company repurchased approximately 1 million shares in the first quarter at a cost of $42.0 million, with a remaining authorization of $396.6 million for share repurchases.